XML 25 R15.htm IDEA: XBRL DOCUMENT

JOINT VENTURE FOR DEVELOPMENT OF APO E MIMETIC PEPTIDE MOLECULE AEM-28 AND ANALOGS (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended		12 Months Ended	104 Months Ended
	Mar. 31, 2013	Mar. 31, 2012	Dec. 31, 2012	Mar. 31, 2013
Cash paid	$ 0	$ 0	$ 0	$ 4,058
Lipimetix [Member]
Patent rights acquired			1,045	3,187
Noncontrolling interest			(667)	(667)
Cash paid			$ 378	$ 4,436

The amount of intangibles that an Entity acquires in a noncash (or part noncash) acquisition. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.

+ References+ Details